These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3127026

  • 1. Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin.
    Schoutens A, Verhas M, Dourov N, Bergmann P, Caulin F, Verschaeren A, Mone M, Heilporn A.
    Calcif Tissue Int; 1988 Feb; 42(2):136-43. PubMed ID: 3127026
    [Abstract] [Full Text] [Related]

  • 2. The effects of calcitonin and colchicine on the cellular response to diphosphonate.
    Rowe DJ, Hausmann E.
    Br J Exp Pathol; 1980 Jun; 61(3):303-9. PubMed ID: 7426385
    [Abstract] [Full Text] [Related]

  • 3. Effect of salmon calcitonin on experimental osteoporosis induced by ovariectomy and low-calcium diet in the rat.
    Mochizuki K, Inoue T.
    J Bone Miner Metab; 2000 Jun; 18(4):194-207. PubMed ID: 10874598
    [Abstract] [Full Text] [Related]

  • 4. Effects of clodronate on immobilization bone loss.
    Minaire P, Depassio J, Berard E, Meunier PJ, Edouard C, Pilonchery G, Goedert G.
    Bone; 1987 Jun; 8 Suppl 1():S63-8. PubMed ID: 2961357
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae.
    Kawaguchi H, Pilbeam CC, Woodiel FN, Raisz LG.
    J Bone Miner Res; 1994 Feb; 9(2):247-53. PubMed ID: 8140938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Indomethacin inhibition of tenotomy-induced bone resorption in rats.
    Thompson DD, Rodan GA.
    J Bone Miner Res; 1988 Aug; 3(4):409-14. PubMed ID: 3223355
    [Abstract] [Full Text] [Related]

  • 8. Whole-body irradiation inhibits the escape phenomenon of osteoclasts in bones of calcitonin-treated rats.
    Nakamura T, Toyofuku F, Kanda S.
    Calcif Tissue Int; 1985 Jan; 37(1):42-5. PubMed ID: 3922595
    [Abstract] [Full Text] [Related]

  • 9. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae.
    Sone T, Kohno H, Kikuchi H, Ikeda T, Kasai R, Kikuchi Y, Takeuchi R, Konishi J, Shigeno C.
    Endocrinology; 1992 Dec; 131(6):2742-6. PubMed ID: 1306984
    [Abstract] [Full Text] [Related]

  • 10. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH, Ransjö M, Ljunggren O, Klaushofer K, Hoffmann O, Peterlik M.
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of salmon calcitonin on bone resorption: morphological study of the tibial growth plate in rats.
    Pazzaglia UE, Zatti G, Di Nucci A, Coci A.
    Calcif Tissue Int; 1993 Feb; 52(2):125-9. PubMed ID: 8443688
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
    McSheehy PM, Farina C, Airaghi R, Allievi E, Banfi S, Bertolini D, Ferni G, Frattola D, Oneta S, Pinza M.
    Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of diphosphonate-blocked bone mineralization. Evidence that calcitonin promotes mineralization.
    Boris A, Hurley JF, Trmal T, Mallon JP, Matuszewski DS.
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):351-61. PubMed ID: 463451
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
    Flanagan AM, Chambers TJ.
    Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
    [Abstract] [Full Text] [Related]

  • 15. [Calcitonin and bone aging].
    Reginster JY.
    Pathol Biol (Paris); 1997 Jan; 45(1):52-6. PubMed ID: 9097847
    [Abstract] [Full Text] [Related]

  • 16. Reversibility of the inhibitory effect of salmon calcitonin on bone resorption in rats.
    Pazzaglia UE, Zatti G, Rolla P, Di Nucci A.
    Acta Orthop Scand; 1994 Apr; 65(2):142-6. PubMed ID: 8197845
    [Abstract] [Full Text] [Related]

  • 17. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C.
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [Abstract] [Full Text] [Related]

  • 18. Effects of prostacyclin and prostaglandin E1 (PGE1) on bone resorption in the presence and absence of parathyroid hormone.
    Conaway HH, Diez LF, Raisz LG.
    Calcif Tissue Int; 1986 Mar; 38(3):130-4. PubMed ID: 3085891
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the effects of anabolic steroids, calcitonin and 25-hydroxycholecalciferol on the spongy bone of rats].
    Carrozzo M, Cantatore FP, Pallante R, Lo Sasso F, D'Amore M, Pipitone V.
    Rev Rhum Mal Osteoartic; 1985 Jan; 52(1):17-9. PubMed ID: 3992151
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ, Caulin F.
    Bone; 1986 Jan; 7(1):17-22. PubMed ID: 3964494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.